CClinicalTrials.gg
RecruitingNCT03608280TOR-3DUpdated May 6, 2023

Efficiency of 3D-printed Implant Versus Autograft for Orbital Reconstruction (TOR-3D)

An interventional study of Bone autograft and Orbital reconstruction by 3D-printed porous titanium implant in Significant Bone Defect in the Orbit, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-05-06.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Two scenarios may result in significant bone defect in the orbit: surgical oncology (meningioma, cancers of the upper aerodigestive tract) or severe trauma. This defect in the bone substance may affect the orbital floor, medial wall or lateral wall. These injuries can result in functional complications such as enophthalmos and diplopia, and an esthetic impact affecting the quality of life. The most frequent complication in orbital traumas is enophthalmos (10-20% according to publications).

The aim of bone substance reconstruction is to restore the volume and the internal shape of the orbit. The gold standard is autologous bone grafts. The surgery which usually lasts 2 to 3 hours depending on the number of walls involved, can lead to ophthalmological or esthetic complications. Its results are unsatisfactory, and the use of titanium implants would allow a reconstruction of the orbital volume more optimal than the autograft.

The development of computer-assisted techniques permitted implants evolution: initially peri-operatively preformed, today patient specific implant can be obtained from data of CT-scan. In cranioplasties, a randomized study showed better results at 12 months of these implants compared to the autograft. Their success rate is close to 100% with less than 5% of postoperative complication, while the rate used for cortical graft reconstructions is 20-25%.

Today, 3D printing of patient-specific porous titanium implants is possible. A study has shown that they allow a more accurate reconstruction compared to preformed implants. This innovation is available in France but it has a high cost (2,000 euros on average) and is currently not refunded. However, the use of this technology would reduce the operating time and the morbidity per- and post-operative, with functional and esthetic results superior to those obtained with bone autograft.

02

Conditions studied

  • Significant Bone Defect in the Orbit

Keywords

  • orbital reconstruction
  • 3D-printed patient specific porous titanium implant
  • autologous bone graft
  • medico-economic study
03

In context

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient between 18 to 90 years old
  • Presenting a defect in the bone substance of an orbital wall (floor, lateral or medial): at least 6 months following a oncologic surgery (in particular meningioma or carcinoma of the upper aerodigestive tract) OR post-traumatic;
  • With a defect of the unilateral orbital bone substance described as complex on the CT-scan: fracture in the posterior third of one walls; fracture extended to two walls (floor and lateral wall, or medial wall and orbital floor); comminutive fracture of at least one of the walls; fracture with more than half of one of the walls tipped over;
  • Presenting an enophthalmos ≥ 3 mm OR an enophthalmos ≥ 2mm with diplopia;
  • Patient with a programmed orbital reconstruction;
  • For patients who have had oncologic surgery, validation of a multidisciplinary consultation meeting;
  • Whose contralateral orbital anatomy is healthy (absence of : bone defect, diplopia, ptosis or other condition affecting aesthetics);
  • Patient who gave its written informed consent to participate to the study;
  • Affiliated to a social insurgence regime or similar.

Exclusion criteria

Exclusion Criteria:

  • Defect of bone substance extended to the upper and / or intermediate floors of the skull-base;
  • For patients who have undergone oncologic surgery, patients with uncontrolled cancer proliferation;
  • Defect of bone substance from the skull vault;
  • Osteo-meningeal Breach;
  • Patient whose understand the French questionnaire EQ-5D-3L;
  • Follow up not possible during 18months (judgement of investigator)
  • Patient with hypersensitivity to metallic materials;
  • Major patient protected by the Law;
  • Pregnant or breastfeeding woman
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
92 participants (estimated)

Study arms

  • Active comparator
    Autograft

    Reconstructive surgery by autologous bone graft (bone autograft). It is the gold standard strategy.

    Procedure: Bone autograft

  • Experimental
    3D implant

    Orbital reconstruction by 3D-printed porous titanium implant (PorousiTi®, laboratoire OBL/MATERIALISE). The device is a custom-made porous titanium implant processed by selective laser melting (SLM technique)

    Procedure: Orbital reconstruction by 3D-printed porous titanium implant

Interventions

  • ProcedureBone autograft

    The principle of this surgery is based on the removal of a portion of the outer bone layer from the vault of the skull in order to have a flat and solid bone element (cortical bone), which can be carved freehand to better replace the defective bone wall.

  • ProcedureOrbital reconstruction by 3D-printed porous titanium implant

    From data of a patient's CT-scan, it is possible to perform a "mirroring". The unaffected orbit is mirrored onto the affected orbit, via a virtual treatment planning, in order to rely on facial symmetry to virtually restore healthy anatomy. From this simulation, the implant is 3D-printed by Selective Laser Melted (SLM) technique using titanium powder. This technique enabling the creation of custom-made implants is called computer-aided design and computer-aided manufacturing (CAD-CAM). After sterilization, the implant is ready to be placed during a surgical procedure.

06

What researchers measure

Primary outcomes

  1. Incremental cost per quality-adjusted life-years (QALY) gained

    QALY will be measured by EQ-5D-3L questionnaire. At 18 months post reconstruction, we can estimate most of the costs of surgery and its consequences. Incremental cost per quality-adjusted life-years (QALY) gained between patients with 3D-printed patient specific porous titanium implant or autologous bone graft for orbital reconstruction.

    Time frame: 18 months

07

Study locations

1 of 1 sites recruiting
  • Hospices Civils de Lyon, Groupement Hospitalier Sud Chirurgie maxillo-faciale
    Pierre-Bénite, 69495, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03608280
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Jul 31, 2018
Start date
May 4, 2023
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
May 6, 2023

Study contacts

Jean-Thomas BACHELET
Contact
jean-thomas.bachelet@chu-lyon.fr
+33 4 26 73 26 44
Magali HANSER
Contact
magali.hanser@chu-lyon.fr
+33 4 72 11 57 65

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion